Manager × security

Endowment Wealth Management, Inc. WST holdings history

Who else holds this security? →

WEST PHARMACEUTICAL SERVICES · CUSIP 955306105 · CIK 1904477

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Endowment Wealth Management, Inc. reported 13.24K WST (shares), valued at $4.75M, or 1.84% of its reported non-derivative portfolio. Filed 2026-08-06.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.84%
Shares
13.24K
13,241
Reported value
$4.75M
USD

Shares increased 0.08%; reported value increased 43.34%, and weight changed +0.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.84%13,241SEC filing ↗Filed Aug 6, 2026Combination report
Q1 20261.47%13,231SEC filing ↗Filed May 8, 2026Combination report
Q4 20251.67%13,219SEC filing ↗Filed Feb 9, 2026Combination report
Q3 20251.57%13,208SEC filing ↗Filed Nov 6, 2025Combination report
Q2 20251.49%13,196SEC filing ↗Filed Jul 25, 2025Combination report
Q1 20251.90%13,183SEC filing ↗Filed May 9, 2025Combination report
Q4 20243.11%14,150SEC filing ↗Filed Feb 7, 2025Combination report
Q3 20242.79%14,140SEC filing ↗Filed Nov 6, 2024Combination report
Q2 20243.39%14,130SEC filing ↗Filed Aug 1, 2024Combination report
Q1 20244.18%14,123SEC filing ↗Filed May 8, 2024Combination report
Q4 20234.13%14,115SEC filing ↗Filed Feb 7, 2024Combination report
Q3 20234.75%14,107SEC filing ↗Filed Oct 31, 2023Combination report

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20234.75%14,107$5.29MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Oct 31, 2023
Q4 20234.13%14,115$4.97MShares increased 0.06%; reported value decreased 6.10%, and weight changed -0.62 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 7, 2024
Q1 20244.18%14,123$5.59MShares increased 0.06%; reported value increased 12.44%, and weight changed +0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 8, 2024
Q2 20243.39%14,130$4.65MShares increased 0.05%; reported value decreased 16.71%, and weight changed -0.79 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 1, 2024
Q3 20242.79%14,140$4.24MShares increased 0.07%; reported value decreased 8.81%, and weight changed -0.60 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 6, 2024
Q4 20243.11%14,150$4.63MShares increased 0.07%; reported value increased 9.20%, and weight changed +0.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 7, 2025
Q1 20251.90%13,183$2.95MShares decreased 6.83%; reported value decreased 36.32%, and weight changed -1.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 9, 2025
Q2 20251.49%13,196$2.89MShares increased 0.10%; reported value decreased 2.17%, and weight changed -0.41 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 25, 2025
Q3 20251.57%13,208$3.46MShares increased 0.09%; reported value increased 20.00%, and weight changed +0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 6, 2025
Q4 20251.67%13,219$3.64MShares increased 0.08%; reported value increased 4.97%, and weight changed +0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 9, 2026
Q1 20261.47%13,231$3.32MShares increased 0.09%; reported value decreased 8.82%, and weight changed -0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 8, 2026
Q2 20261.84%13,241$4.75MShares increased 0.08%; reported value increased 43.34%, and weight changed +0.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2026
Endowment Wealth Management, Inc. · WEST PHARMACEUTICAL SERVICES

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1904477","quarter":"2026Q2","cusip":"955306105"}

get_institutional_manager_history
{"cik":"1904477","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.